Gefitinib Terminated Phase 2 Trials for Breast Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00206492Trial of ZD1839 (Iressa) and Tamoxifen in Breast Cancer Patients
NCT00206414Arimidex/Faslodex/Iressa Study: A Trial Using Arimidex, Faslodex and Iressa in Women With Breast Cancer
NCT00082667Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast